The activation of NF-κB pathways is the hallmark of psoriasis, and results in the production of excessive inflammatory cytokines (e.g., TNF-α, IL-6, IL-17), which leads to the progression of psoriasis [91]. This evidence concerns the gene IL17A and psoriasis.